Vertical: AnDBase Year: 201910 Sections
Market Size (2019)
—
Projected (2027)
—
CAGR (2017–2027)
N/A
Key Players
12+
1.1 Definition
Global Myomectomy market is expected to grow at ~5.8% CAGR during the forecast period, 2020-2027.
XXXX
· 2019: USD 12,834.04 Million (Approximately)
· 2027: USD 20,148.79 Million (Approximately)
CAGR (2019–2027)
· 5.8% (Approximately)
Key Market Drivers
· Rising prevalence of uterine fibroids, and increasing demand for diagnosis and treatment of uterine disorder
· Increasing demand for medical devices for gynecology procedures
Key Market Opportunities
· Opportunity 1
Key Vendors
· Halt Medical, Inc
· Boston Scientific Corporation
· CooperSurgical Inc
· C. R. Bard, Inc
· Hoffmann-La Roche Ltd
· General Electric Company
· KARL STORZ SE & Co. KG
· Richard Wolf Medical Instruments
· NIDEK CO., LTD.
Myomectomy Market is a key focus area for market intelligence and strategic research.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMyomectomy a surgical procedure for the removal uterine fibroids. Uterine fibroids are common noncancerous growth in the uterus of women at their childbearing age, causing symptoms such as heavy bleeding during menstrual cycle, increased menstrual cramping, pain in pelvis or lower back, and swelling enlargement of the abdomen.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansAfter estimating the market sizes and estimates, the numbers are verified with industry participants and key opinion leaders. The wide network of industry participants add value to the research and verify the numbers and estimates provided in the study. At the last stage of the research process, a final report is prepared, which is then published on different websites as well as distributed through various channels. The below figure contains the different stages of the research process to produce the report.
DATA MINING
Data mining is an extensive part of our research process. It involves the procurement of market data and related information from different verified and credible sources. This step helps to obtain raw information about the components of the industry and their deployment, the monetary process for different end uses, the pool of market participants, and the nature of the industry and scope of the study. The data mining stage comprises both primary and secondary sources of information.
SECONDARY RESEARCH
In the secondary research process, various sources are used to identify and gather industry trends and information for the research process. We at Wantstats have access to some of the most diversified and extensive paid databases, which give us the most accurate data/information on markets sizes, components, and pricing. Mentioned below is a detailed list of sources that have been used for this study. Please note that this list is not limited to the names as mentioned; we also access other data sources depending on the need.
Market Sizing & Revenue
Qualitative Information & Trends
Company Websites
· White Papers
· Magazines
· Company Websites
· Annual Reports
· Press Releases
· Investor Presentations
· Paid Databases
· Authenticated Directories
· Independent Studies
· Internal Audit Reports & Archives
· Government and Regulatory Published Material
· The European Medicines Agency
· Food Drug Administration
· Myomectomy Advocacy Network.
· XXXXX
· XXXXX
Annual Reports
Investor Presentations
Authenticated Directories
Hoover’s, Factiva, Bloomberg
PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
Respondents
Data Points Received
Manufacturers
· Market Size
· Top of the Mind Key Market Players
· Direct Competitors
· Company Market Shares
· Growth Rate (%)
· Market Trends and Prominent Market Drivers
· Major Products
· Product Cost
· Commercial Availability
· Upcoming Technologies
End User
· Product Cost
· Adoption Rate & Maintenance Cost
BREAKDOWN OF PRIMARY RESPONDENTS
FORECASTING METHODS
We at Wantstats follow an extensive process for arriving at market estimations, which involves the use of multiple forecasting Methods as mentioned below.
Forecasting Methods
Description
Qualitative and Quantitative Analysis
A combination of qualitative approach, i.e., primary interviews with industry experts to understand the interviewees’ opinions and judgments, more commonly known as the Delphi method, and quantitative analysis to forecast future data based on historical and current data.
Weighted Average Approach
Via this approach, future data is calculated based on the mean of the past data under the assumption that some factors affecting the market in the past will continue to have a similar impact in the future.
Drift Method
This approach is used to vary the forecast, that is increase or decrease market factor over time depending on various parameters affecting the change in the trends of the market.
Time Series Methods
Integration of several time series methods such as moving average, moving weighted average, linear prediction, and trend estimation are applied while determining the year-on-year growth rate and the compound annual growth rate of the market being studied.
Causal/Econometric Forecasting Methods
Various economic factors such as inflation rate, fiscal policies, changes in government regulations, taxes, labour costs, and interest rates are taken into consideration while determining the current market size and predicting the future market growth rate.
Judgmental Methods
This involves collection of intuitive judgment, opinions, and probability estimates from industry experts in the case of new or upcoming markets/technologies for which no prior data is available.
Regression Analysis
This type of statistical modelling is carried out for predicting and forecasting dependent and independent variables that will directly or indirectly impact the market.
Probabilistic Forecasting
This forecasting method is carried out to assign a probability to every possible outcome ranging from the least optimistic to highly optimistic, which helps in gauging the market under stable conditions.
PESTLE Analysis
Political, economic, social, technological, legal, and environmental factors are taken into consideration while deriving the fluctuations in the growth rate of the market.
Porter’s Five Forces Analysis
By understanding the supplier-side and demand-side factors, the current market scenario can be estimated, and future market scenario predicted, which aid in deriving the growth rate of the market.
RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
Understanding and penetrating the market in terms of valuation is crucial task in the process of business research. This again becomes significantly important while investing and choosing the business opportunities. In this regard, we at Wantstats performs two ways market sizing approach simultaneously namely top-down and bottom-up approaches. In this step, we place different data points, numeric attributes, information and industry trends at an appropriate space to deduce the estimates & forecast values over the coming years. We use different mathematical models to estimate the market sizes of different economies and segments. Each of which is further summed up to define the total market.
We at Wantstats owns a proprietary statistical tool for market estimations which helps us to comprehend market size estimates & forecasts for different markets and industries.
In the bottom-up approach, the revenue of key companies and their shares in the market is assessed to deduce the market size. More than 80% key players operating in the myomectomy market is studied. The segmental revenue of each player is analyzed and the market size for amblyopia market is extracted from the segmental/product revenue with the help of secondary and primary research. This extracted market size for amblyopia market is then validated from industry experts and partner consultants. This derived market size contributes around 65 – 70% of the total global market share in terms of revenue for myomectomy market. Using the application of data triangulation method, the overall global market size is estimated.
TOP-DOWN APPROACH
This overall market size is then used in the top-down procedure to estimate the size of the other sub-markets with the help of percentage splits of the market segments from secondary and primary research. The demand side analysis is conducted in which spent analysis for major industries in each region is studied. The end-users considered in the scope of this research study contributes around 70 % of the total in the amblyopia market.
The countries considered in the scope of myomectomy market are US, Canada, Mexico, the UK, Germany, France, Italy, Spain, Switzerland, Austria, Belgium, Denmark, Finland, Greece, Hungary, Italy, Luxembourg, the Netherlands, Norway, Poland, Portugal, Slovakia, Sweden, Romania, Ireland, China, Japan, Malaysia, Indonesia, the Philippines, South Korea, Singapore, India, Australia & New Zealand, South Africa, Egypt, Nigeria, Saudi Arabia, Qatar, the UAE, Bahrain, Kuwait, and Oman, Brazil, Argentina, Chile, and others. However, the number of countries vary from devices to devices and it solely depends on the product approvals in the respective countries and the commercial availability of the products.
Below figure explains the process of market estimation using independent tool employed by our analysts to get the sizing of the market.
Wantstats Analysis Overview
As a part of the market engineering, the both top-down and bottom-up approaches are utilized along with data triangulation models to derive and verify the market sizes and forecast over the coming years.
DATA TRIANGULATION
After arriving at the overall market sizes, the total market is divided into several segments and sub segments. Again, market breakdown and data triangulation procedures are implemented wherever applicable, to complete the overall market engineering process and to collect the exact statistics for all segments and sub-segments. The data was triangulated by studying various factors and trends from both demand and supply sides. Along with this, the market was validated by using both top-down and bottom-up approaches.
VALIDATION
Validation is the most important stage of the report making process. Validation via an intricately designed feedback process helps us to finalize the sizing estimates and forecast for the final collation. Extensive primary research is performed to verify the information. This includes telephonic & personal interviews, mails, feedback forms, questionnaires and polling options/answers with the group of relevant people. Validation helps to duly check the authenticity of the key industry trends, market dynamics, company market share, different business models & their conclusions.
Base Year
2019
Historical Period
2017 – 2018
Forecast Period
2020 – 2027
Primary Interviews
150+
Historical data (2017–2019) and forecast period (2019–2027)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
See plans for professionals or small and medium businesses.
Analytical insights on Myomectomy Market covering market dynamics, competitive landscape, and strategic outlook.
Myomectomy Market represents a significant market opportunity with multiple growth drivers across regions and segments.
1.1 Covid-19 Impact on global Myomectomy market Demand Supply Analysis
XXXXXXX Pricing Analysis
XXXXXX Consumption Analysis
XXXXXX Impact on Key Players
XXXXXXX
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 106 companies operating in the Myomectomy Market market, including revenue, employee count, and market positioning where available.
Showing 106 of 106 companies
Company Headquarters: Massachusetts, US Founded: 1979 Workforce: ~36,000 Company Working: Boston Scientific Corporation is a worldwide developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. The company collaborates with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, and increase efficiencies. Its product portfolio is majorly divided into endoscopy, interventional cardiology, neuromodulation, peripheral interventions, rhythm management, and urology & pelvic health. In addition, Boston Scientific serves hospitals, clinics, outpatient facilities and medical offices across the world. Boston Scientific Corporation's manufacturing facilities are located across Malaysia, the US, and Ireland. Apart from this, it has a presence in countries like Japan, the Netherlands, France, Poland, India, China, Turkey, South Africa, and Singapore.
Bayer is a German life-science group with three businesses: Crop Science, Pharmaceuticals and Consumer Health. It is the world's largest combined seed, trait and crop-protection supplier, a mid-sized prescription-drug maker, and a top-five self-care company. Fiscal 2025 sales were EUR 45.6 billion. The 2018 purchase of Monsanto brought leading corn and soybean genetics but also glyphosate and PCB litigation, which has consumed well over EUR 10 billion in settlements and produced net losses in 2023, 2024 and 2025. Under CEO Bill Anderson the company has cut management layers, held the dividend at the legal minimum, and concentrated on four priorities: rebuilding the pharma pipeline, containing litigation, reducing debt and improving crop profitability. In 2026 a 7–2 U.S. Supreme Court ruling on federal pre-emption and a proposed USD 7.25 billion class settlement moved the litigation closer to resolution, though the settlement still awaits final court approval. --- **Company's own description.** Bayer describes itself as a global enterprise with core competencies in the life-science fields of health care and nutrition, operating under the mission "Health for all, Hunger for none" (Annual Report 2025; press boilerplate 2026). Bayer AG is a holding company; operations sit in subsidiaries worldwide. In fiscal 2025 the Group had about 88,000 employees, sales of EUR 45.6 billion and R&D expenses of EUR 5.8 billion. **Independent characterisation.** Bayer is best understood as three distinct businesses sharing a balance sheet, a brand and a legal liability. Crop Science (47 percent of FY2025 sales) is an input supplier to farmers. It earns money from proprietary seed and biotech traits, from chemical and biological crop protection, and to a small extent from digital farming subscriptions. Seed and trait revenue carries royalty-like economics: Bayer licenses traits to other seed companies, and two licensing settlements with Corteva lifted results in Q4 2025 and Q1 2026. The business is strongly seasonal, with Northern Hemisphere sales concentrated in the first half and Latin American sales in the second. Pharmaceuticals (39 percent of sales) discovers, develops and sells prescription medicines, concentrated in cardiovascular and renal disease, oncology, women's health and ophthalmology, plus a radiology unit selling contrast agents and injector hardware. Revenue is almost entirely product sales, with some licence income (for example U.S. Xarelto royalties from Johnson & Johnson, and Eylea outside the United States under a collaboration with Regeneron). The division is in the middle of a patent transition: Xarelto and Eylea are declining while Nubeqa and Kerendia are growing quickly. Consumer Health (13 percent of sales) sells non-prescription brands through pharmacies, mass retail and e-commerce. It is a branded consumer-goods model with stable margins and low capital intensity. **Revenue model mix.** Bayer does not disclose a product/service/licensing split. On the evidence of the Annual Report 2025, the large majority of revenue is product sales; licensing income is embedded in Crop Science seed and trait lines and in Pharmaceuticals; subscription revenue (Climate FieldView, radiology software) is immaterial at Group level. An exact percentage split is not publicly disclosed. **Value-chain position.** Bayer is a research-based originator and manufacturer. It owns discovery, development, active-ingredient and finished-product manufacturing, and commercial organisations, and sells through distributors, retailers, wholesalers, hospitals and pharmacies rather than directly to end users in most markets. **Customers and end markets.** Farmers, agricultural retailers and distributors, and seed licensees (Crop Science); wholesalers, hospitals, physicians, pharmacy chains, governments and payers (Pharmaceuticals); pharmacies, supermarkets, drugstores and online retailers (Consumer Health).
KARL STORZ SE & Co. KG is the leading manufacturer of endoscopes. The company offers various endoscopic instruments for human and veterinary medical examination as well as for industrial applications. The company has a worldwide presence to support and consult its customers, it has more than 50 subsidiary stores in over 40 countries such as the US, Cuba, Belgium, China, and others.
Hoffmann-La Roche Ltd — AnD
CooperSurgical Inc — AnD
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
